Washington, D.C. — House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) and Subcommittee on Health Chair Brett Guthrie (R-KY) today announced a legislative subcommittee hearing titled “Examining Policies to Improve Seniors’ Access to Innovative Drugs, Medical Devices, and Technology.” 

"Millions of Americans rely on Medicare to access lifesaving and life-sustaining treatment and care. Despite the importance of the program, some of its outdated policies and procedures leave many of our seniors with fewer options or unable to receive the most innovative and effective means of care. This hearing will give members an opportunity to discuss a variety of possible policy improvements, including strengthening the Part D prescription drug program, that will give seniors better access to the best treatments, medical devices, and technology available,” said Chairs Rodgers and Guthrie.  

Subcommittee on Health hearing titled “Examining Policies to Improve Seniors’ Access to Innovative Drugs, Medical Devices, and Technology” 

WHAT: A hearing to discuss legislative proposals to improve seniors’ access to innovative drugs, medical devices, and technology. 

DATE: Tuesday, September 19, 2023  

TIME: 10:00 AM ET  

LOCATION: 2322 Rayburn House Office Building    

WITNESSES: 

• Dr. Dora Hughes, Acting Director, Center for Clinical Standards and Quality; Acting Chief Medical Officer, Centers for Medicare & Medicaid Services 
• Mr. John Dicken, Director, Health Care – Public Health and Private Markets, U.S. Government Accountability Office 

LEGISLATION TO BE DISCUSSED: 

• H.R. 1691, the Ensuring Patient Access to Critical Breakthrough Products Act of 2023 (Reps. Wenstrup, Bilirakis, Cardenas, Guthrie, Eshoo)  
• H.R. 2408, the Access to Innovative Treatments Act of 2023 (Reps. Barragan and Joyce)   
• H.R. 133, the Mandating Exclusive Review of Individual Treatments (MERIT) Act (Reps. Buchanan and Barragan)  
• H.R. 2407, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (Reps. Arrington, Hudson, and Ruiz)  
• H.R. 1199, the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023 (Reps. Dunn, Peters, Trahan, Blunt Rochester, Miller-Meeks, Tonko, Joyce, Kuster, and Bucshon) 
• H.R. 3842, the Expanding Access to Diabetes Self-Management Training Act of 2023 (Reps. Schrier, Bilirakis, DeGette, Bucshon, and Ruiz)  
• H.R. 4818, the Treat and Reduce Obesity Act (TROA) of 2023 (Reps. Wenstrup, Ruiz, and Miller-Meeks) 
• H.R. 1458, the Access to Prescription Digital Therapeutics Act of 2023 (Reps. Hern, Johnson, and Matsui)  
• H.R. 2880, the Protecting Patients Against PBM Abuses Act (Reps. Carter and Blunt Rochester)  
• H.R. 5074, the Kidney PATIENT Act of 2023 (Reps. Carter and Kuster)  
• H.R. 4881, To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program. (Rep. Malliotakis)  
• H.R. 5372, the Expanding Seniors’ Access to Lower Cost Medicines Act of 2023 (Reps. Joyce and Peters) 
• H.R. 5376, the Share the Savings with Seniors Act (Reps. Miller-Meeks and Peters)  
• H.R. 5371, the Choices for Increased Mobility Act of 2023 (Rep. Joyce)  
• H.R. 5394, the Expanding Remote Monitoring Access Act (Reps. Balderson and Porter)  
• H.R. 5386, the Cutting Copays Act (Reps. McGarvey and Bilirakis)  
• H.R. 5393, the Transparency and Fairness for Pharmacies Act (Reps. Griffith and Carter)  
• H.R. 5389, the National Coverage Determination Transparency Act (Rep. Guthrie)  
• H.R. 5395, the Coverage Parity for Medicare Patients of 2023 (Rep. Harshbarger)  
• H.R. 5396, the Coverage Determination Clarity Act of 2023 (Rep. Bucshon) 
• H.R. 5392, the Timely Access to Coverage Decisions Act of 2023 (Rep. Dunn) 
• H.R. 5397, the Joe Fiandra Access to Home Infusion Act of 2023 (Reps. Fitzpatrick and Dunn)  
• H.R. 5385, the Medicare PBM Accountability Act (Reps. Landsman and Harshbarger) 
• H.R. 5388, the Supporting Innovation for Seniors Act (Rep. Balderson) 
• H.R. 5380, To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage. (Rep. Sarbanes) 

This notice is at the direction of the Chair. The hearing will be open to the public and press and will be live streamed online at https://energycommerce.house.gov/. If you have any questions concerning the hearing, please contact Jolie Brochin with the Committee staff at Jolie.Brochin@mail.house.gov. If you have any press-related questions, please contact Christopher Krepich at Christopher.Krepich@mail.house.gov.